A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

[1]  P. Cooke,et al.  Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer , 2000, European Urology.

[2]  S. Radulović,et al.  Concomitant Radiotherapy and Carboplatin in Locally Advanced Bladder Cancer , 1999, European Urology.

[3]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[4]  B N Bundy,et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.

[5]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[6]  A. Fyles,et al.  A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. , 1998, Gynecologic oncology.

[7]  B. Chauvet,et al.  [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study]. , 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[8]  B. Chauvet,et al.  [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival]. , 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[9]  I. Tannock,et al.  Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. James Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.

[11]  B. Chauvet,et al.  Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. , 1996, The Journal of urology.

[12]  N. Petrelli,et al.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Wahlqvist,et al.  Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1 , 1996 .

[14]  F. Freiha,et al.  A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. , 1996, The Journal of urology.

[15]  M. Parmar,et al.  Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration. , 1995, British journal of urology.

[16]  L. Mazzucchelli,et al.  Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. , 1994, The Journal of urology.

[17]  F. Baillet,et al.  Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Hammond,et al.  Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. , 1993, International journal of radiation oncology, biology, physics.

[19]  H. Itatani,et al.  Preliminary results of concurrent cisplatin and radiation therapy in locally advanced bladder cancer. , 1992, British journal of urology.

[20]  J. Dunn,et al.  Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. , 1991, British journal of urology.

[21]  W. H. Kern,et al.  The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. , 1991, The Journal of urology.

[22]  C. Logothetis,et al.  Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors. , 1991, Journal of the National Cancer Institute.

[23]  M. Rotman,et al.  Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. , 1990, International journal of radiation oncology, biology, physics.

[24]  H. Bloom,et al.  Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. , 1988, British journal of urology.

[25]  G. Jakse,et al.  Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder , 1985, Cancer.

[26]  L. Freedman,et al.  Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy. , 1983, British journal of urology.

[27]  D. Wallace Cancer of the bladder. , 1968, The American journal of roentgenology, radium therapy, and nuclear medicine.

[28]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[29]  R. Sauer,et al.  Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. , 1998, International journal of radiation oncology, biology, physics.

[30]  G. Jakse,et al.  Concurrent adriamycin and radiotherapy in locally advanced bladder cancer. , 1989, British journal of urology.

[31]  G. Jakse,et al.  Hyperfractionated, accelerated radiotherapy and concurrent chemotherapy in locally advanced bladder cancer. , 1987, European urology.